Hollsteen
← Coherent

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $13.0M · 10-Q 0001564590-15-009922 filed Nov 6, 2015Research and development · Q2 FY2016: $12.0M · 10-Q 0001564590-16-012460 filed Feb 8, 2016Research and development · Q3 FY2016: $15.0M · 10-Q 0001564590-16-018663 filed May 9, 2016Research and development · Q4 FY2016: $20.0M · 10-K 0001564590-16-024750 filed Aug 26, 2016Research and development · Q1 FY2017: $22.0M · 10-Q 0001564590-16-028337 filed Nov 8, 2016Research and development · Q2 FY2017: $24.0M · 10-Q 0001564590-17-000837 filed Feb 1, 2017Research and development · Q3 FY2017: $25.0M · 10-Q 0001564590-17-008137 filed May 2, 2017Research and development · Q4 FY2017: $26.0M · 10-K 0001564590-17-017901 filed Aug 21, 2017Research and development · Q1 FY2018: $26.0M · 10-K 0001564590-19-032471 filed Aug 16, 2019Research and development · Q2 FY2018: $28.0M · 10-Q 0001564590-19-002429 filed Feb 8, 2019Research and development · Q3 FY2018: $31.0M · 10-K 0001564590-19-032471 filed Aug 16, 2019Research and development · Q4 FY2018: $33.0M · 10-K 0001564590-19-032471 filed Aug 16, 2019Research and development · Q1 FY2019: $33.0M · 10-Q 0001564590-18-028645 filed Nov 8, 2018Research and development · Q2 FY2019: $34.0M · 10-Q 0001564590-19-002429 filed Feb 8, 2019Research and development · Q3 FY2019: $36.0M · 10-Q 0001564590-19-017964 filed May 9, 2019Research and development · Q4 FY2019: $36.0M · 10-K 0001564590-19-032471 filed Aug 16, 2019Research and development · Q1 FY2020: $36.0M · 10-Q 0001564590-19-042658 filed Nov 12, 2019Research and development · Q2 FY2020: $108M · 10-Q 0001564590-20-004069 filed Feb 10, 2020Research and development · Q3 FY2020: $95.0M · 10-Q 0000820318-20-000006 filed May 11, 2020Research and development · Q4 FY2020: $100M · 10-K 0000820318-20-000023 filed Aug 26, 2020Research and development · Q1 FY2021: $78.0M · 10-Q 0000820318-20-000029 filed Nov 9, 2020Research and development · Q2 FY2021: $85.0M · 10-Q 0000820318-21-000004 filed Feb 9, 2021Research and development · Q3 FY2021: $83.0M · 10-Q 0000820318-21-000012 filed May 7, 2021Research and development · Q4 FY2021: $84.0M · 10-K 0000820318-21-000017 filed Aug 20, 2021Research and development · Q1 FY2022: $89.0M · 10-Q 0000820318-21-000022 filed Nov 9, 2021Research and development · Q2 FY2022: $95.0M · 10-Q 0000820318-22-000004 filed Feb 9, 2022Research and development · Q3 FY2022: $97.0M · 10-Q 0000820318-22-000010 filed May 10, 2022Research and development · Q4 FY2022: $96.0M · derived · 10-K 0000820318-23-000016 filed Aug 18, 2023Research and development · Q1 FY2023: $121M · 10-Q 0000820318-22-000027 filed Nov 9, 2022Research and development · Q2 FY2023: $129M · 10-Q 0000820318-23-000005 filed Feb 8, 2023Research and development · Q3 FY2023: $126M · 10-Q 0000820318-23-000009 filed May 10, 2023Research and development · Q4 FY2023: $123M · derived · 10-K 0000820318-24-000016 filed Aug 16, 2024Research and development · Q1 FY2024: $113M · 10-Q 0000820318-23-000029 filed Nov 7, 2023Research and development · Q2 FY2024: $111M · 10-Q 0000820318-24-000004 filed Feb 6, 2024Research and development · Q3 FY2024: $127M · 10-Q 0000820318-24-000009 filed May 7, 2024Research and development · Q4 FY2024: $127M · derived · 10-K 0000820318-25-000014 filed Aug 15, 2025Research and development · Q1 FY2025: $132M · 10-Q 0000820318-24-000035 filed Nov 6, 2024Research and development · Q2 FY2025: $144M · 10-Q 0000820318-25-000004 filed Feb 5, 2025Research and development · Q3 FY2025: $151M · 10-Q 0000820318-25-000009 filed May 7, 2025Research and development · Q4 FY2025: $156M · derived · 10-K 0000820318-26-000020 filed Aug 14, 2026Research and development · Q1 FY2026: $155M · 10-Q 0000820318-25-000019 filed Nov 5, 2025Research and development · Q2 FY2026: $166M · 10-Q 0000820318-26-000006 filed Feb 4, 2026Research and development · Q3 FY2026: $186M · 10-Q 0000820318-26-000013 filed May 6, 2026Research and development · Q4 FY2026: $216M · derived · 10-K 0000820318-26-000020 filed Aug 14, 2026156a216a13Q1 FY2016Q4 FY2026
$MResearch and development · Q1 FY2025: $132M · 10-Q 0000820318-24-000035 filed Nov 6, 2024Research and development · Q2 FY2025: $144M · 10-Q 0000820318-25-000004 filed Feb 5, 2025Research and development · Q3 FY2025: $151M · 10-Q 0000820318-25-000009 filed May 7, 2025Research and development · Q4 FY2025: $156M · derived · 10-K 0000820318-26-000020 filed Aug 14, 2026Research and development · Q1 FY2026: $155M · 10-Q 0000820318-25-000019 filed Nov 5, 2025Research and development · Q2 FY2026: $166M · 10-Q 0000820318-26-000006 filed Feb 4, 2026Research and development · Q3 FY2026: $186M · 10-Q 0000820318-26-000013 filed May 6, 2026Research and development · Q4 FY2026: $216M · derived · 10-K 0000820318-26-000020 filed Aug 14, 2026156a216a132Q1 FY2025Q4 FY2026Q4 FY2025
Q4 FY2025
156a$M
derived
All values (44)
PeriodValue ($M)Status
Q4 FY2026216derived
Q3 FY2026186reported
Q2 FY2026166reported
Q1 FY2026155reported
Q4 FY2025156derived
Q3 FY2025151reported
Q2 FY2025144reported
Q1 FY2025132reported
Q4 FY2024127derived
Q3 FY2024127reported
Q2 FY2024111reported
Q1 FY2024113reported
Q4 FY2023123derived
Q3 FY2023126reported
Q2 FY2023129reported
Q1 FY2023121reported
Q4 FY202296derived
Q3 FY202297reported
Q2 FY202295reported
Q1 FY202289reported
Q4 FY202184reported
Q3 FY202183reported
Q2 FY202185reported
Q1 FY202178reported
Q4 FY2020100reported
Q3 FY202095reported
Q2 FY2020108reported
Q1 FY202036reported
Q4 FY201936reported
Q3 FY201936reported
Q2 FY201934reported
Q1 FY201933reported
Q4 FY201833reported
Q3 FY201831reported
Q2 FY201828reported
Q1 FY201826reported
Q4 FY201726reported
Q3 FY201725reported
Q2 FY201724reported
Q1 FY201722reported
Q4 FY201620reported
Q3 FY201615reported
Q2 FY201612reported
Q1 FY201613reported

CSV with all sources · Technical ID: rnd

More metrics for Coherent

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$156M (derived)
Period
Q4 FY2025, ended Jun 30, 2025 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 582M − 426M = $156M (FY value from 10-K 0000820318-26-000020; 9-month value from the Q3-10-Q)
Source
10-K, filed Aug 14, 2026 · 0000820318-26-000020
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$156MAug 14, 202610-K 0000820318-26-000020derived · confidence 1. · current